In Axcan Scandipharm v. Reed Smith, Axcan, a pharmaceutical company, claimed that the firm engaged in an impermissible conflict that led to disclosure of confidential information by the firm to a second client.

According to an opinion written by Philadelphia’s Commerce Case Management Program Judge Howland W. Abramson, Reed Smith represented Axcan in a patent litigation case brought against the company in federal court. Axcan was indemnified by American Home Products Corp. (AHP) — which is now known as Wyeth — and/or Eurand International, and AHP/Eurand paid Reed Smith for its representation of Axcan under that indemnification agreement, Abramson said.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]